Related Experiment Video
Updated: Jun 26, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Long-cycle treatment in oral contraception]
Herbert Kuhl1, Martin Birkhäuser, Alfred Mueck
1Universitätsklinik für Gynäkologie und Frauenheilkunde, J. W. Goehte-Universität, Frankfurt. H.Kuhl@em.uni-frankfurt.de
Therapeutische Umschau. Revue Therapeutique
|January 31, 2009
Summary
Many women prefer fewer periods or amenorrhea for improved quality of life and hygiene. Long-cycle oral contraceptives (OCs) offer increased safety and reduced hormonal fluctuations, benefiting various gynecological conditions.
Area of Science:
- Gynecology
- Reproductive Health
- Pharmacology
Context:
- Surveys indicate a widespread desire among women for altered menstrual patterns, including reduced frequency or amenorrhea.
- This preference is consistent across women with natural cycles and those using oral contraceptives (OCs).
- Key motivations include reduced bleeding, enhanced hygiene, improved quality of life, and decreased blood loss.
Purpose:
- To inform women about the benefits of long-cycle oral contraceptive (OC) use.
- To address the misconception that suppressing menstruation is "unnatural."
- To highlight the increased contraceptive safety and reduced hormonal fluctuations associated with long-cycle regimens.
Summary:
- Long-cycle OC use increases contraceptive efficacy and minimizes hormonal fluctuations during the pill-free interval, thereby reducing associated somatic and mental symptoms.
- This regimen is particularly beneficial for women experiencing conditions such as endometriosis, hypermenorrhea, dysmenorrhea, and polycystic ovary syndrome.
- It also addresses estrogen-deficiency symptoms like migraine and premenstrual syndrome, offering a therapeutic advantage.
Impact:
- Empowers women with knowledge regarding OC options that align with their preferences for menstrual regulation.
- Provides a scientific basis for adopting long-cycle OC use, potentially improving patient adherence and outcomes.
- Offers a strategy to manage gynecological symptoms and enhance overall well-being through optimized hormonal therapy.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.